HLTH Tema Healthcare AI ETF
Quote as of Aug 26, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 29.86 | Day Range | 29.64 – 31.22 |
| 52-Week Range | 24.88 – 31.22 | Volume | 6.70K |
| Avg Volume | 12.55K | AUM | $0.00 (Aug 27, 2026) |
| Expense Ratio | 0.00% | Yield (TTM) | — |
| NAV | 29.22 | Premium/Discount | +1.44% indicative |
| Inception | Jul 21, 2026 | Holdings | — |
| Issuer | Tema | Exchange | NASDAQ |
| Category | Artificial Intelligence | Index Tracked | Not stated in source data |
| CUSIP | 87975E768 | ISIN | US87975E7682 |
| Management | Actively managed (per issuer description) | ||
About this ETF
Tema Healthcare AI ETF is an actively managed exchange-traded fund that focuses on the intersection of artificial intelligence and healthcare. It targets global life science, tech, and medical companies driving AI-integrated drug discovery, robotic surgery, and healthcare operational efficiencies.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +18.69% | — | — | — | — | — | — | — | — |
| Total return | +18.68% | — | — | — | — | — | — | — | — |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 25, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.00% | Annual cost of a $10,000 investment | $0.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 21, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 33 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | 10X GENOMICS INC | TXG | 6.72% | 4.86K | $310.5K |
| 2 | TWIST BIOSCIENCE CORP | TWST | 5.67% | 1.92K | $262.0K |
| 3 | ILLUMINA INC | ILMN | 4.89% | 1.06K | $226.0K |
| 4 | CYTOKINETICS INC | CYTK | 4.89% | 2.93K | $226.0K |
| 5 | NATERA INC | NTRA | 4.56% | 648 | $210.5K |
| 6 | VERTEX PHARMACEUTICALS INC | VRTX | 4.55% | 389 | $210.2K |
| 7 | REVOLUTION MEDICINES INC | RVMD | 4.47% | 976 | $206.7K |
| 8 | COGENT BIOSCIENCES INC | COGT | 4.27% | 5.58K | $197.1K |
| 9 | INTUITIVE SURGICAL INC | ISRG | 3.89% | 480 | $179.8K |
| 10 | ABSCI CORP | ABSI | 3.66% | 18.23K | $169.2K |
| 11 | ARROWHEAD PHARMACEUTICALS INC | ARWR | 3.61% | 1.90K | $166.5K |
| 12 | GUARDANT HEALTH INC | GH | 3.57% | 983 | $165.0K |
| 13 | DEXCOM INC | DXCM | 3.57% | 1.83K | $165.0K |
| 14 | STOKE THERAPEUTICS INC | STOK | 3.48% | 5.12K | $160.9K |
| 15 | PARABILIS MEDICINES INC | PBLS | 3.33% | 3.88K | $153.6K |
| 16 | CARDINAL HEALTH INC | CAH | 3.26% | 658 | $150.3K |
| 17 | THERMO FISHER SCIENTIFIC INC | TMO | 3.18% | 234 | $146.8K |
| 18 | GENERATE BIOMEDICINES INC | GENB | 3.04% | 8.78K | $140.5K |
| 19 | DYNE THERAPEUTICS INC | DYN | 3.03% | 5.39K | $140.0K |
| 20 | TEMPUS AI INC | TEM | 2.98% | 2.07K | $137.8K |
| 21 | HEARTFLOW INC | HTFL | 2.60% | 2.56K | $119.9K |
| 22 | KYMERA THERAPEUTICS INC | KYMR | 2.32% | 883 | $107.3K |
| 23 | BEAM THERAPEUTICS INC | BEAM | 2.18% | 3.55K | $100.8K |
| 24 | OSCAR HEALTH INC | OSCR | 1.98% | 2.90K | $91.4K |
| 25 | RELAY THERAPEUTICS INC | RLAY | 1.94% | 4.55K | $89.6K |
Click a ticker to see every ETF that owns it.
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | — | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | — | Last payment | — |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
No distributions in our database for this fund — it may not pay them, or history has not loaded yet.
Risk Statistics
Liquidity
| Volume today | 6.70K | Average volume | 12.55K |
| AUM | $0.00 | Premium/Discount | +1.44% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for HLTH
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.